AIHTA - Publications - Search - Items where Subject is "WI 600-650 Anus. Rectum"
Number of items at this level: 18.

Adlbrecht, C. and Warmuth, M. (2012): Radiofrequency ablation of primary tumours of the gastrointestinal tract (colorectal and pancreatic cancer). Decision Support Document 58.

Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Fischer, S. and Zechmeister, I. (2011): Sacral Nerve Stimulation for Fecal Incontinence. Rapid Assessment 004.

Fischer, S. and Zechmeister-Koss, I. (2014): Vasoprotectives: Efficacy and safety of capillary stabilising agents for venous insufficiency or haemorrhoidal diseases. HTA-Projektbericht 79.

Gassner, L. (2021): Implantation of Bulking Agents for Faecal Incontinence. Update 2021. Decision Support Document 87/1.

Goetz, G. (2021): Stool DNA testing for colorectal cancer (CRC) screening. AIHTA Policy Brief 011.

Grössmann, N. (2021): Pembrolizumab (Keytruda®) as monotherapy for the first-line treatment of MSI-H or dMMR colorectal cancer. Update April 2021. Oncology Fact Sheet Nr. 34.

Grössmann, N. (2020): Encorafenib (Braftovi®) in combination with cetuximab for the treatment of adult patients with metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. Update July 2020. Oncology Fact Sheet Nr. 7.

Hintringer, K. and Wild, C. (2009): Colon Hydrotherapy for defecation disorders. Systematic Review. Decision Support Document 32.

Rothschedl, E. and Nachtnebel, A. (2014): Bevacizumab (Avastin®) as maintenance therapy after first progression on bevacizumab for patients with advanced colorectal carcinoma. DSD: Horizon Scanning in Oncology 46.

Rothschedl, E. and Nachtnebel, A. (2013): Regorafenib (Stivarga®) for heavily pretreated patients with metastatic colorectal cancer (mCRC). DSD: Horizon Scanning in Oncology 40.

Schmidt , L. and Lohr, P. and Prenner, A. and Poerio, E. and Ceresola, E. and Andretta, M. and Cavazzana, A. (2019): Robot-assisted surgery in thoracic and visceral indications. HTA-Projektbericht 108.

Wild, C. (2003): [Electric stimulation for faecal incontinence]. HTA-Newsletter 23: pp. 2-3.

Wild, C. (2002): [Stapled haemorrhoidectomy]. HTA-Newsletter 10: p. 4.

Winkler, R. (2015): Injectable bulking agents for faecal incontinence. Decision Support Document 87.

Wolf, S. (2021): Ripretinib (Qinlock®) for the treatment of patients with advanced gastrointestinal stromal tumour (GIST). Oncology Fact Sheet Nr. 62.

Wolf, S. (2021): Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®) for the treatment of patients with mismatch repair deficient (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer. Update September 2021. Oncology Fact Sheet Nr. 51.

Wolf, S. and Stanak, M. (2018): Allogeneic mesenchymal stem cells for Crohn’s disease-associated complex perianal fistulas. Decision Support Document 111.

This list was generated on Thu Oct 21 01:00:11 2021 CEST.